GeneNews partners to sell ColonSentry in China

GeneNews (TSX:GEN) signed a binding term sheet with GeneDiagnostics, a private clinical research and services company in China, for the non-exclusive rights to market ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer. GeneNews expects negotiations will lead to a formal marketing partnership agreement by the end of June. [...]

Lorus gets first patent in China

Lorus Therapeutics (TSX:LOR) received allowance of its first patent in China for novel drug candidates from its small molecule program. The Chinese patent covers composition of matter for Lorus’ lead anticancer small molecule LOR-253, as well as composition and uses of its lead antimicrobial compound LOR-220.  Lorus has similar patents pending worldwide for the two [...]